About Carlsmed
Carlsmed is a commercial-stage medical technology company that pioneers AI-enabled personalized spine surgery solutions. Their core mission is to enhance patient outcomes and reduce healthcare costs associated with spine surgery by transforming the standard of care. The company’s proprietary aprevo® Technology Platform integrates advanced AI-driven software with 3D-printed, patient-specific interbody fusion devices.
This platform enables detailed 3D surgical planning, leveraging AI-enabled segmentation and prior outcomes data to develop personalized surgical plans and devices tailored to each patient’s unique anatomy and pathology. Initially focused on lumbar fusion procedures, Carlsmed has expanded its offerings to include cervical fusion surgeries, with recent launches and clinical evaluations of its aprevo® Cervical Interbody System and corra™ Cervical Plating System. The technology aims to provide precise alignment, optimized fit, and has demonstrated a significant reduction in revision rates compared to standard implants.
What Physicians Need to Know
Carlsmed's aprevou00ae platform offers spine surgeons a transformative approach by integrating AI-driven personalized planning with patient-specific 3D-printed implants. This enables unparalleled precision in achieving optimal spinal alignment and significantly reduces the risk of complications and revision surgeries, as evidenced by clinical data. Physicians benefit from a comprehensive pre-operative understanding through digital twin technology, intuitive 3D visualizations via the myaprevou00ae app for intra-operative guidance, and the flexibility to adapt plans. The system supports data-driven decision-making, streamlines workflows, and is designed to complement existing surgical navigation and robotic systems, ultimately leading to more predictable and improved long-term patient outcomes. Furthermore, the CMS New Technology Add-On Payment (NTAP) for cervical fusion procedures can provide elevated reimbursement for hospitals, making this innovative technology more accessible.
While the provided sources highlight an end-to-end digital workflow and compatibility with current surgical navigation and spinal robot software, specific details regarding direct integrations with Electronic Medical Records (EMRs), Picture Archiving and Communication Systems (PACS), or other hospital IT infrastructure are not explicitly detailed. Further inquiry would be needed to understand their full integration capabilities.
What the Web Says
Carlsmed is a medical technology company specializing in personalized spine fusion devices, particularly aprevo. The company has received positive attention for its innovative, patient-specific approach to spinal surgery, aiming to improve outcomes and reduce complications. While product reviews highlight the potential benefits for patients and surgeons, employer reviews are less prevalent, but generally indicate a positive work environment.
Overall: PositiveStrengths
- Personalized, patient-specific implants (aprevo) lead to better surgical outcomes.
- Utilizes AI and predictive analytics for surgical planning.
- Potential to reduce complications and reoperations.
- Positive impact on patient recovery and quality of life.
- Strong focus on innovation and technological advancement.
- Collaborative and supportive work culture (based on limited employer reviews).
Limitations
- Limited availability of comprehensive employer reviews on major platforms.
- As a newer technology, long-term efficacy data is still accumulating.
- Potential for higher costs associated with personalized implants compared to standard options.
- Adoption rate may be slow due to the need for new surgical workflows.
- Specific product reviews from platforms like G2 or Capterra are not readily available as it's a medical device.
- No significant negative product or company reviews found across searched platforms.
Based on reviews from: GlobeNewswire, Healthcare IT News, Spine publications/journals (implied from product reviews), LinkedIn (for employer insights), Reddit (limited relevant discussions)
Last updated: 2026-07-20
Videos
News, demos, and interviews about Carlsmed.
Videos load interactively. If none appear, search YouTube for Carlsmed →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Carlsmed.
Related Companies
Precision Medical Ventures, Inc. Dba Revealdx (RevealDx) is a Seattle-based healthcare AI company focused on dramatically improving lung cancer outcomes through non-invasive diagnosis. They develop advanced, radiomics and AI-enabled, lung cancer decision support software. Their flagship product, RevealAI-Lung, is a Computer-Assisted Diagnostic (CADx) software that analyzes patient lung computed tomography (CT) images to provide information […]
SafeBeat Rx is a healthcare AI company focused on transforming cardiac care by expanding access to remote patient monitoring (RPM), continuous telemetry, event monitoring, and software-enabled remote therapeutic monitoring (RTM). The company’s core offering is an integrated technology that utilizes automated artificial intelligence-based software to analyze electrocardiogram (ECG) data. This technology is designed to replace […]
Measure Labs, Inc., operating as PreemptiveAI, Inc., is a healthcare AI company focused on transforming healthcare from reactive disease management to proactive risk identification and prevention. The company has developed a “revolutionary” foundation model, a large-scale machine learning model, that interprets biomedical signals from smartphones and wearable devices to predict health outcomes in real-time. This […]
EarliPoint Health, formerly EarliTec Diagnostics, is a healthcare AI company dedicated to transforming autism care through innovative, FDA-cleared eye-tracking technology. The company’s core product, the EarliPoint System, is a medical device designed to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children aged 16 months through 95 months (7 […]
Onera B.V., operating as Onera Health, is a Dutch med-tech company that is transforming sleep diagnostics and monitoring with its innovative, self-applied, no-wire polysomnography (PSG) solution. [12, 19] Founded as a spin-off from the imec research center, a leader in nanoelectronics and digital technologies, Onera aims to make clinical-grade sleep studies broadly accessible, convenient, and […]
Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]